What is it about?
Pharmacotherapy is the standard treatment for patients with metastatic or locally advanced urogenital cancers. It can prolong survival or improve symptoms; however, it is not usually curative and may cause adverse effects which lead to the deterioration of the patient’s quality of life. Therefore, it is important to decide on the course of treatment in consideration of the patient's perception and expectations. Recently, new agents have been developed and they provide several treatment options and extended treatment periods. In this study, we examined patients’ perception and expectations over the course of pharmacotherapy.
Photo by National Cancer Institute on Unsplash
Why is it important?
The percentage of patients who accurately perceived the objective of pharmacotherapy increased over the course of pharmacotherapy. The rate of patients who were willing to receive treatment and try other treatments when the standard treatment became too difficult to continue remained consistently high.
Read the Original
This page is a summary of: Change of genitourinary cancer patients’ perception and expectations over the course of pharmacotherapy, PLoS ONE, November 2022, PLOS,
You can read the full text:
The following have contributed to this page